Joaquin Mateo

I am a physician-scientist and Medical Oncologist specialised in prostate cancer; my main research interest it the development of new, less toxic and more effective treatments for patients with advanced prostate cancer but, particularly, study how can we be more precise in selecting the best drug for each patient at every moment of the disease evolution. I believe molecular stratification of prostate cancer can help delivering more precise cancer care for our patient, ultimately improving patient outcome. After completing medical oncology training, I pursue a fellowship in early phase clinical trials in oncology at the Drug Development Unit of The Royal Marsden NHS Trust (London, UK). I progressively focused in the development of new therapeutic strategies for prostate cancer and began my laboratory work in the field of prostate cancer genomics under the mentorship of Prof Johann de Bono at The Institute of Cancer Research (London, UK), where I obtained my PhD. Since Nov 2017, I am the Group Leader for the newly created Prostate Cancer Translational Research Group at the Vall Hebron Institute of Oncology (VHIO, Barcelona, Spain), as well as medical oncologist at the Vall Hebron University Hospital. My group holds basic molecular biology, genomics, bioinformatics and clinical research expertise to develop a translational research program aiming to improve prostate cancer patient care through precision medicine strategies. Among other research grants, I have received personal fellowship grants from the EU Commission (Marie Curie Program, 2019-2021), the Prostate Cancer Foundation (Young Investigator Program, 2016-2019), as well as project grants from the US Department of Defense and the Spanish Ministry of Science (FIS Program).